A 12-week randomized, double-blind, parallel-group, placebo-controlled trial with and open-label, 12-week extension, multicenter to evaluation of the efficacy of escitalopram for the treatment of depression in Alzheimer's disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Purpose : to Evaluation of the Efficacy of Escitalopram for the Treatment of Depression in Alzheimer\'s Disease Trial Design : A 12-week, randomized, double-blind, parallel-group, placebo-controlled trial with an open-label, 12-week extension
Epistemonikos ID: f5f9796c24336d20afeca6b5fd2545390ebe6ac5
First added on: May 11, 2024